Featuring
Veterinary Targeted Therapies in the Time of COVID-19, Part 1
Dr. London is a global leader in veterinary targeted therapies. She discusses potential risks to veterinary staff, the value of targeted therapy in times of constrained PPE resources, and the effects of COVID-19 on research activity.
Webinars